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Abstract
Cardiac catheterisation is an essential tool to evaluate patients who require ECMO
support for severe haemodynamic impairment. In the first part of this chapter, we
describe  the  equipment,  teamwork,  expertise,  techniques  and precautions  that  are
necessary to carry out safe and effective cardiac catheterisation on ECMO. We have
moved on from an early pioneering era to a stage where the multidisciplinary team
approach has been worked out in detail, using operational procedures that deal with
the technical challenges and minimise the risks of ECMO catheterisation and interven‐
tion. In the second part of the chapter, we explain in detail how cardiac catheterisa‐
tion and intervention on ECMO contribute to the management of (1) post-operative
congenital heart disease patients, (2) cardiac patients who suffer sudden haemodynam‐
ic deterioration, (3) patients with low cardiac output who require left heart decompres‐
sion because of extracorporeal support, (4) patients with haemodynamically unstable
arrhythmias and (5) haemodynamically unstable patients who require percutaneous
coronary intervention. We also provide state-of-the-art information on the elective use
of ECMO to support congenital and structural catheter interventions. Acute survival
and long-term outcome are  now related  to  the  underlying  conditions  rather  than
complications of the catheterisation procedure itself.
Keywords: ECMO, cardiac catheterisation, catheter intervention, congenital heart dis‐
ease, myocarditis, cardiomyopathy, balloon septostomy, atrial septal stent, arrhyth‐
mia, radiofrequency ablation, percutaneous coronary intervention, structural
intervention
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1. Introduction
Since cardiac catheterisation and transcatheter intervention in patients on ECMO was pio‐
neered in the late 1980s, interventional cardiologists and ECMO teams have learned to work
together to provide rapid accurate diagnosis and safe interventional solutions for patients with
the most challenging anatomical problems and the most fragile physiologies. In the current era,
experienced teams provide excellent results. The aim of this chapter was to describe state-of-
the-art practice in this area.
Catheterisation is most commonly required in the setting of extracorporeal support in the
following scenarios:
a. Following surgery for congenital heart disease
b. When acute haemodynamic collapse occurs in a cardiac patient unrelated to surgery
c. To decompress the left heart in patients with poor left ventricular function
d. Patients with haemodynamically unstable refractory arrhythmias
e. Percutaneous coronary intervention in patients with severe haemodynamic instability
f. Elective ECMO support for high-risk congenital and structural transcatheter interven‐
tional procedures
The first part of this chapter will address the practical issues related to carrying out cardiac
catheterisation in patients on ECMO. The second part of the chapter will focus on up-to-date
knowledge and practice in each of the clinical scenarios listed above.
2. Practical tips for ECMO catheterisation
2.1. Staffing
To maximise the safety of ECMO support, the entire team should be familiar with all local
ECMO protocols and experienced in moving patients on ECMO. When out of the intensive
care unit, the patient is accompanied by the bedside ECMO specialist, ECMO coordinator and
a perfusionist. Surgical expertise is available in the event of a cannulation issue, and an
anaesthetist or intensive care specialist always accompanies the patient. The circuit is main‐
tained as if it were in the intensive care unit with the same routine circuit checks and monitoring
of anticoagulation. The ECMO specialist needs to ensure that there is an adequate supply of
syringes and ACT cartridges close by and that the ECMO emergency box containing spare
connectors and pigtails accompanies the patient at all times. Each member of the team is tasked
with surveillance of a different part of the circuit or patient during the transport.
2.2. Transport between intensive care and the catheter laboratory
The ECMO system should be mounted on a mobile cart. As most modern ECMO systems are
capable of operating on battery power for extended periods, the patient and circuit can be
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transferred in a slow and steady manner to the catheter suite. The patient must be fully
monitored and sufficient gas supply must be carried to provide oxygen both to the ECMO
circuit, as sweep gas, and to the ventilator. All drug infusions should be continued. The ECMO
circuit often represents the safest and most reliable access point as pre-existing central lines
may need to be rewired and upsized to permit the procedure. It is, however, recommended
that at least one well-functioning peripheral cannula is available in case there is a circuit-related
complication. As with most critical care transfers, the ECMO patient should be appropriately
sedated or anaesthetised prior to leaving the unit. All studies that have assessed the process
of patient transport have described excellent outcomes with no cannula displacement,
morbidity or mortality [1–3].
2.3. Cannulation
The exact method of ECMO cannulation is largely dictated by patient factors, mainly the
weight and age of the patient, but consideration needs to be given to any anatomical variation
or loss of vessels either secondary to prolonged ITU stay, surgery or previous catheter
interventions. In children below 10 kg in weight, the carotid artery and the jugular vein are
the vessels of choice. For most patients, a right-sided cut-down centred on the medial border
of the sternocleidomastoid muscle approximately 1.5–2 cm above the clavicle provides
excellent access to both of these vessels. Cannulas between 8 and 14 Fr may be inserted
depending on the size of the patient and vessels and the amount of support required. In
children over 10 kg, cannulation of a femoral vein and artery are preferred. This approach
avoids damage to the carotid artery and alterations to flow of blood to the brain. It must be
remembered that the femoral artery is an end vessel and the distal perfusion of the leg needs
careful consideration in order to prevent limb ischaemia. An additional small cannula either
placed antegradely into the superficial femoral artery or retrogradely into the posterior tibial
artery can be used satisfactorily to prevent critical limb ischaemia. Once inserted, the cannulas
should be firmly secured with at least two sutures.
Occasionally, a patient who is cannulated centrally through an open chest may need treatment
in the catheter laboratory. This is almost exclusively in the post-operative patient and although
possible carries a significantly higher risk than the patient cannulated peripherally. Centrally
placed cannulas are usually shorter and therefore much more prone to being dislodged on
patient movement or during the procedure. For such patients, a surgeon capable of reinserting
the cannula is essential and additional caution must be exercised by the entire team.
2.4. In the catheter laboratory
A briefing is essential so that the cardiologist understands the ECMO set-up but also so that
the ECMO team may fully appreciate what the diagnostic or interventional procedure
involves. It is relatively straight forward to position the ECMO circuit to the side of the patient
if the catheter procedure can be achieved utilising simple antero-posterior imaging. However,
for more complex procedures, requiring imaging through a wide range of planes, we have
found it preferential to position both the ECMO pump and the oxygenator on the catheter
table, away from the traditional ECMO cart (Figure 1). By securing the circuit on the table, the
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cardiologist can move the patient and position the C-arm without fear of inadvertent decan‐
nulation or damage to the circuit components. It is essential to ensure that the circuit is
connected to a main’s power supply and that the ECMO heater unit is running to prevent
unwanted cooling of the patient throughout the procedure. When possible, oxygen should be
connected to the wall supply.
Figure 1. The ECMO circuit secured to the catheter table.
2.5. Vascular access
As the patient is heparinised, it is preferable to avoid new punctures. Existing central venous
lines or arterial pressure monitoring lines are therefore exchanged over a wire for a sheath
whenever possible. However, new punctures are required in the majority of procedures and
complications are surprisingly rare [2, 4, 5]. Only one study described complications, in 13%
patients, including venous thrombosis, lower extremity oedema without thrombosis, transient
loss of peripheral pulses and lower extremity compartment syndrome requiring fasciotomy
[3]. Patients often have a history of previous operations, interventions and prolonged intensive
care. It is therefore important to check in advance whether any vessels are known to be
occluded and to confirm vessel patency with vascular ultrasound before attempting new
access. It is preferable to use vascular ultrasound during puncture attempts to minimise
complications [2].
Draping the patient and maintaining sterility can be challenging, as old lines are being
exchanged for sterile sheaths, requiring extra care to lift the line that is being removed away
from the patient without contaminating the sterile field. Changing gloves after removing the
old line and a second pair of hands to assist the exchange are advisable.
To avoid the morbidity of additional vascular access, angiography can be carried out by
injecting contrast directly via the ECMO cannula, using a three-way adaptor in the connector
[2]. This manoeuvre requires a coordinated sequence of transient flow cessation, contrast
injection, saline flush, image acquisition and recommencement of flow [2]. With this technique,
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it is possible to get good images of the aortic root and coronary arteries, particularly if the aorta
distal to the cannula is transiently occluded in patients with an open chest [2]. It is also possible
to cut a Y-connector into the arterial limb of the ECMO circuit, through which catheters can
be inserted [6–9]. The blind end of the Y-connector is closed with a haemostatic valve (Check-
Flo Performer accessory adapter, Cook Medical, USA). Although this allows direct access to
the heart, without the need for further punctures, catheters are more difficult to manipulate
and torque takes longer to transmit because of friction inside the cannula and Y-connector.
This loss of feel may hamper the procedure. For this reason, we reserve this approach for simple
diagnostic procedures and for cases where vessels are absent or thrombosed or attempts to
gain alternative access have failed. When the catheter is completed, the Y-connector must be
removed. One study describes similarly placing a Y-connector in the venous limb of the ECMO
circuit to obviate the need for venous puncture [2]. We remain concerned that this approach
has the potential to rapidly entrain air into the venous circulation because of the negative
pressure generated by the centrifugal pump.
2.6. Angiography
The ECMO circuit will normally be positioned to the right of the patient’s head with neck
cannulation. This usually makes it impossible to bring in the lateral camera C-arm, so most
ECMO catheters are carried out with single plane fluoroscopy and angiography. Before
starting the case, the image intensifier should be moved through a full range of right and left
Figure 2. Clutter in the X-ray field. Legend—The image includes ECMO cannulas, chest drains, surgical clips, swabs, a
nasogastric tube, a cardiac catheter and a vascular occlusion device (dashed arrow). There is a significant stenosis at
the pulmonary artery bifurcation (solid arrow) following cardiac surgery (superior cavopulmonary shunt).
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anterior oblique angles, to check whether any equipment is impeding the movement of the C-
arm. The ECMO circuit and ancillary equipment should be positioned to maximise the range
of camera angles. Test screening is carried out to check that equipment does not encroach on
the field of view in the camera angles that are likely to be used during the case. ECG leads and
electrodes that are not radiolucent may need to be removed, saturation probes repositioned,
chest drain tubing moved and bundles of epicardial pacing wires taped over the abdomen
rather than the chest. If it is anticipated that angles approaching the lateral plane may be
required, the arms should be lifted up and supported either side of the head, taking care not
to displace the ECMO cannulas. Sometimes items of equipment that cannot be moved, for
example ECMO cannulas, chest drains, pacing leads, swabs with radio-opaque markers, chest
spreaders and clamps, clutter the X-ray field and overlie the area of interest (Figure 2). Unusual
camera angles may therefore be needed to properly visualise the area without hardware
encroaching on the image. For angiography, 1 ml/kg contrast, or even lower volumes for low
flow states, gives good image quality [2].
2.7. Catheter technique
Catheter manipulation is not usually any more difficult because of the extracorporeal support,
though appreciation of catheter position is sometimes limited by single plane fluoroscopy.
ECMO flow may need to be diminished or temporarily discontinued to document cardiac
haemodynamics. ECMO can actually facilitate intervention, as it offers a stable haemodynamic
platform to carry out interventions that might otherwise cause significant haemodynamic
derangement. Furthermore, if the chest is open and a surgeon is close at hand, it is justifiable
to accept a greater risk of vessel rupture during balloon angioplasty or stenting as the area is
rapidly accessible for surgical repair. Complications during catheterisation are rare. One study
reported myocardial perforation in 2 patients (3%), dealt with by inserting a pericardial drain
without the need for surgery [5]. Another study reported retroperitoneal haematoma
secondary to arterial trauma when removing an embolised coil [4]. Even in the earliest study,
transseptal puncture was carried out in a fully anticoagulated state without complication [10].
The safety of transseptal puncture can now be enhanced by intraprocedural transoesophageal
echocardiography, even in small children, using a micro-TOE probe.
2.8. Return to the intensive care unit
On completing the catheter, the circuit is resecured to the ECMO trolley if needed and the
patient is returned to the intensive care unit. If additional vascular access was utilised for the
procedure, this should be left in place until the patient returns to ICU. In this way, the clotting
status of the patient can assessed prior to line removal. Although some have recommended
that sheaths should be left in place until the patient is weaned from ECMO, most sheaths can
be safely removed and bleeding controlled by manual compression [2, 4]. The ongoing need
for anticoagulation and inherent platelet dysfunction mean that pressure needs to be applied
for longer than would be expected for non-ECMO patients. Alternatively, venous sheaths can
be exchanged for a central line of equal outer diameter, venous puncture sites can be closed
with a Z-suture or the vessels can be repaired surgically.
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3. Clinical scenarios where catheterisation on ECMO is required
3.1. ECMO catheterisation following surgery for congenital heart disease
3.1.1. Why is ECMO required following surgery?
ECMO support may be required following surgery for congenital heart disease in the following
circumstances: (a) failure to separate from cardiopulmonary bypass; (b) ventricular dysfunc‐
tion with low cardiac output in the immediate post-operative period; (c) unexpected cardiac
arrest requiring extracorporeal CPR; (d) lung disease; (e) pulmonary hypertension; and (f)
refractory arrhythmias [11]. In such cases, it is important to quickly assess the integrity of the
surgical repair and establish whether there are any residual anatomical problems that require
correction, as studies have shown between 6% and 28% of post-operative patients requiring
ECMO have residual lesions [11–14].
3.1.2. Why is cardiac catheterisation required following surgery?
In the majority of cases, echocardiography does not provide complete information because
ventilation, dressings, pacing wires, chest drains, air in the anterior mediastinum and an open
chest restrict the available echocardiographic windows. In one study, where ECMO was
established using central cannulation with the chest open, only 17% of residual lesions were
identified by echocardiography [11]. Other studies confirm that echocardiography has clear
limitations in this context, with residual problems detected in at best 41% and at worst 19% of
patients [1, 5]. Echocardiography is particularly poor at identifying problems with branch
pulmonary arteries and systemic to pulmonary artery shunts. In contrast, in one of the largest
studies on post-operative ECMO, cardiac catheterisation identified 78% of residual lesions.
About 91% of cardiac catheterisation procedures yielded unexpected diagnostic information
of clinical importance [11]. Both surgeon and cardiologist therefore need to remain open to the
fact that something may have been missed. In 70–83% of cases, management is altered by the
results of cardiac catheterisation [1, 2, 4, 5, 11]. The findings may result in redo surgery, cardiac
intervention or elective withdrawal of ECMO in patients with severe neurological impairment
or lack of myocardial recovery. Cardiac catheterisation is therefore mandated whenever there
is any doubt about the cause of the patient’s poor haemodynamic status.
3.1.3. Survival after catheterisation on ECMO
Table 1 shows how outcomes for patients who require cardiac catheterisation on ECMO have
improved over time. The studies listed describe a mixed group of paediatric cardiac ECMO
patients, not just patients who required ECMO in the post-operative period. Nevertheless, the
trend towards improved survival is impressive.
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Outcome 1990–1995 Desjardins et
al. (1999) [4]
1984–2001 Booth et
al. (2002) [5]
2009–2012 Panda et
al. (2014) [2]
2004–2013 Callahan et
al. (2015) [3]
Weaned from ECMO 53% 72% 82% 86%
Discharged from
hospital 
29% 48% 68% 72%
Survival on follow-up 14% 43% 64% 69%
Table 1. Outcomes in patients who have cardiac catheterisation on ECMO.
In a study that included only children on ECMO following paediatric cardiac surgery, children
with residual lesions had 87% survival to decannulation when lesions were detected within 3
days of the operation, compared with 36% survival when the lesions were detected later. Most
lesions were detected by cardiac catheterisation. Survival to discharge was 58% and 18%,
respectively, in the two groups [11]. These findings reinforce the 2011 recommendations of the
American Heart Association that cardiac catheterisation with potential for intervention is
indicated early in the post-operative period in any patient who requires mechanical cardio‐
pulmonary support without a clear cause [15].
3.1.4. The timing of cardiac catheterisation
Although there is a natural tendency to attribute the need for extracorporeal support to
myocardial stun following cardiopulmonary bypass and cross-clamping, if patients fail to
wean from ECMO within 3 days, cardiac catheterisation is strongly advised. Catheterisation
should be carried out earlier if haemodynamic measurements made on PICU or echocardiog‐
raphy suggest a residual problem. In cases where the surgeon suspects a residual problem or
coronary artery issues could result in permanent myocardial damage, it is preferable to
proceed straight from theatre to the cardiac catheterisation laboratory. In our centre, it is
routine to carry out a detailed assessment of every surgical repair in theatre either by TOE or
by epicardial echocardiography. Intracardiac problems are therefore usually identified early
and repaired immediately. In view of this, when a patient fails to wean from ECMO on PICU,
it is likely that any residual lesion will be beyond the reach of echocardiographic imaging.
Branch pulmonary artery problems, aortic problems and distortion, stenosis and thrombosis
of cavopulmonary and aortopulmonary shunts remain a blind spot for the echocardiographer.
3.1.5. Types of catheter procedures required in the post-operative period
Indications for catheterisation include the evaluation of coronary arteries (Figure 3), pulmo‐
nary arteries (Figure 4), pulmonary venous obstruction, aortic obstruction, shunts and
aortopulmonary collaterals. The surgeon who carried out the operation is usually present in
the catheter laboratory at the time of the study. If a residual lesion is identified, our practice is
to convene a short meeting in the catheter laboratory control room with surgeons, cardiologists
and intensivists represented. An immediate decision is made whether the patient should
return to the operating theatre or should proceed to have catheter intervention. About 20–50%
of residual lesions can be dealt with in the catheter laboratory [2, 11, 16]. Interventions include
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duct stenting (Figure 5), shunt angioplasty or stenting, branch pulmonary artery angioplasty
or stenting, coronary stenting, stent fenestration of Fontan circulation, balloon atrial septos‐
tomy, ASD device closure, VSD device closure, coil occlusion of collaterals and catheter-
directed thrombolysis [3, 5, 11, 17]. Complications are rare [2–5, 11, 16]. As the circulation is
fully supported, hybrid procedures are possible, particularly when the chest is open. For
example, branch pulmonary artery stenting can be carried out with a sheath introduced
through the anterior wall of the main pulmonary artery or right ventricular outflow tract. A
greater risk of vessel rupture during angioplasty or stenting can be accepted when the chest
is open, the patient is draped for a surgical procedure and the whole theatre team are scrubbed
and on standby in the catheter laboratory, as the surgeon can quickly control bleeding and
repair even major damage to blood vessels (Figure 4).
Figure 3. Partial occlusion of the left coronary artery post-repair of common arterial trunk. Legend—The arrowheads
show weak opacification of the left coronary artery.
Figure 4. (a) Torsion of the left pulmonary artery following unifocalisation surgery for pulmonary atresia with VSD
and MAPCAS (major aortopulmonary collateral arteries); (b) A premounted stent is positioned across the site of steno‐
sis; (c) The stent is deployed but has a residual waist. As the balloon is inflated to higher pressure, the pulmonary ar‐
tery ruptures at the stenotic anastomotic site and has to be repaired immediately by the surgeon who is on standby.
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Figure 5. Stenting the arterial duct and altering pulmonary artery bands in a hybrid Norwood procedure. (a) Angiog‐
raphy is carried out via a sheath introduced through the anterior wall of the pulmonary artery (solid arrow). The pul‐
monary arteries are not opacified as the bands are too tight; (b) Lateral view showing flow into the aorta after stenting
the arterial duct; (c) Very tight left pulmonary artery band (dashed arrow); (d) Good flow into the pulmonary arteries
with mild proximal narrowing (dashed arrows) after loosening the pulmonary artery bands.
3.2. The cardiac patient with acute haemodynamic collapse unrelated to surgery
3.2.1. When is diagnostic catheterisation indicated?
Neonates who present moribund with shock or profound cyanosis may require urgent
extracorporeal support before a full cardiac evaluation can be carried out. When congenital
heart disease is present, a full diagnosis is usually then secured with transthoracic echocar‐
diography alone. However, it may be difficult to diagnose obstructed total anomalous
pulmonary venous drainage, as its clinical presentation mimics lung disease and pulmonary
venous drainage can be hard to define once VA ECMO has been commenced, even when
ECMO flows are reduced to encourage flow through the pulmonary circulation. In view of
this, ECMO patients have sometimes required cardiac catheterisation to establish or exclude
TAPVD [18, 19]. However, in the current era, every effort is made to establish pulmonary
venous drainage echocardiographically before sick neonates are placed on ECMO. When this
is not possible, contrast CT may offers a less invasive alternative.
3.2.2. Catheter intervention in children on ECMO
When ECMO is initiated to treat shock or cyanosis in cardiac patients, cardiac catheterisation
is normally only necessary when intervention is planned. A wide array of interventions have
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been described following emergency ECMO in paediatric patients, including balloon angio‐
plasty of critical aortic stenosis [1, 20], balloon angioplasty of a restrictive cor triatriatum
membrane [21], balloon atrial septostomy in the context of hypoplastic left heart syndrome
with a restrictive atrial septum [4] and radiofrequency ablation of incessant tachycardia [22,
23].
3.2.3. ECMO salvage as an alternative to balloon atrial septostomy for moribund patients with
transposition of the great arteries
Patients with transposition of the great arteries deserve special mention. When such patients
present profoundly hypoxic and acidotic, the team is under great pressure to perform balloon
atrial septostomy quickly. However, it may sometimes be difficult and time-consuming to gain
vascular access. In such circumstances, it is occasionally easier and quicker to cannulate the
neck vessels for ECMO. Once the patient is on ECMO, balloon atrial septostomy can be
undertaken or the patient can proceed to theatre for an arterial switch procedure after a period
of stabilisation [24].
3.2.4. Catheter intervention in adults on ECMO
Adult patients may also require emergency ECMO support followed by catheter intervention.
Patients with massive pulmonary embolism may need to be resuscitated using extracorporeal
support, following which catheter-directed thrombolytic therapy, catheter embolus fragmen‐
tation or percutaneous thrombectomy can be carried under stable conditions [25–27]. As
structural intervention gains momentum, patients who need ECMO support because of shock
or cardiac failure caused by severe valvar stenosis or regurgitation may increasingly be treated
using transcatheter therapy on extracorporeal support. TAVI has already been carried out
following emergency ECMO [28] and one patient with severe mitral regurgitation requiring
ECMO has been successfully treated with a MitraClip [29]. However, results are likely to better
if ECMO is used to electively support interventional procedures in high-risk patients, before
acute haemodynamic decompensation occurs [28].
3.3. Left heart decompression in patients with poor ventricular function
3.3.1. Why is left heart decompression necessary?
When VA ECMO is commenced to support patients with severe myocardial dysfunction, the
heart may stop ejecting completely because of the increased afterload caused by the extracor‐
poreal circulation. In these circumstances, left ventricular end-diastolic pressure rises sharply
because of acute left heart distension, and the increased wall stress, reduced myocardial
perfusion and subendocardial ischaemia that occur as a consequence compromise recovery of
ventricular function. Left atrial pressure increases, causing pulmonary venous hypertension,
pulmonary oedema and in severe cases pulmonary haemorrhage. Left heart decompression is
necessary to decrease pulmonary oedema, avoid pulmonary haemorrhage and allow myo‐
cardial recovery [30–32].
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3.3.2. Making the decision to decompress the left heart
Approximately 10–20% patients who require ECMO for poor left ventricular function will
require left heart decompression [31–33]. The decision to decompress the left atrium is usually
made within 24 h of commencing ECMO, on the basis of left heart dilation on echocardiogra‐
phy and pulmonary oedema on chest X-ray [32]. Direct surgical left atrial cannulation is
possible in post-operative patients [31, 32]. However, a non-surgical approach is preferable in
patients with myocarditis and post-operative patients where there is a plan to switch to neck
cannulation in order to close the chest.
3.3.3. Percutaneous decompression using drains incorporated into the ECMO circuit
Percutaneous decompression may be achieved by introducing a transseptal left atrial drain
from a femoral venous approach [32, 34–37] or passing a pigtail catheter into the left ventricle
from a femoral artery approach [38, 39]. The return from these drains is incorporated into the
venous limb of the ECMO circuit. However, there are concerns about systemic thromboemb‐
olism when hardware remains in the left heart for a prolonged period of time. Also, transseptal
drains have become less popular in recent years because of problems with kinking, poor flow
and drain movement with patient care [32].
3.3.4. Percutaneous left atrial decompression by opening the atrial septum
In the majority of patients, left atrial decompression is achieved by balloon atrial septostomy
[30, 32, 40]. If prolonged extracorporeal support is anticipated or balloon septostomy fails to
achieve an adequate interatrial communication, atrial septal stenting is carried out [32, 41].
Transseptal puncture is required as a first step in approximately 90% of patients, as only about
10% have a pre-existing interatrial communication [30, 32]. Most transseptal punctures are
carried out using a Brockenbrough needle. Accidental left atrial perforation is a particular
concern as the patient is fully anticoagulated. However, the largest series reported only one
left atrial perforation, which closed without requiring pericardial drainage [32]. Needle
position may be guided by transthoracic or transoesophageal echocardiography to minimise
complications [40, 42]. Radiofrequency transseptal perforation is an alternative and may be
preferable when the septum is very thick, but there is some concern that an accidental burn
hole in the atrial wall may be less likely to close spontaneously. In young infants, it is possible
to perform a Rashkind balloon atrial septostomy, rapidly jerking a septostomy balloon from
the left to the right atrium in order to tear a hole in the atrial septum. Older patients require a
static balloon septostomy, as the septum is too thick for the Rashkind technique to be effective.
3.3.5. Static balloon septostomy
To perform a static balloon septostomy, a long sheath is advanced over the transseptal needle
into the left atrium. A catheter is then advanced through the transseptal sheath and directed
into the left upper pulmonary vein. A wire is passed through the catheter into the pulmonary
vein and the catheter and sheath are withdrawn. A balloon is advanced over the wire until it
is centred across the atrial septum. Balloons are usually in the 12–18 mm range, but smaller
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and larger diameters may be required, depending on patient size [32, 33]. The balloon is then
inflated to tear a hole in the septum (Figure 6). Historically, blade atrial septostomy was carried
out after transseptal puncture to ensure that a large hole could be created, but blade septostomy
has now almost disappeared from practice. If the hole is not big enough to reduce left atrial
pressure to less than about 20 mmHg, a larger balloon can be used, a second hole can be created
by a separate transseptal puncture, a cutting balloon (Boston Scientific, Natick, USA) can be
used to create blade cuts in the margins of the defect to allow more effective balloon dilation,
or atrial septal stenting can be carried out.
Figure 6. Static balloon dilation of the atrial septum with progressively larger balloons.
3.3.6. Stenting the atrial septum
Stenting can be carried out using the ‘dog-bone’ technique described by Stumper et al. (Figure
7) [43] or simply by implanting a straight stent across the septum (Figure 8) [42]. Echocar‐
diography is used to measure the distance from the inferior vena cava to the atrial septum and
from the septum to the pulmonary veins to guide what length of stent should be chosen. The
stent should not project more than about halfway across the atrial cavity, to avoid the risk of
puncturing the atrial wall, particularly when the heart size reduces as the patient recovers.
Transoesophageal echocardiography can be used to check that the stent is accurately centred
on the septum before the balloon is inflated. A hole with a diameter of about 4–5 mm is usually
adequate [33]. To achieve this, when a straight stent is implanted, it is usually mounted on an
8- to 10-mm-diameter balloon, which is inflated at low pressure to leave a waist at the septum.
In the current era, premounted stents are often used [42]. When the dog-bone technique is
used, a 15-mm balloon should be used with a 4- to 5-mm constraining loop that prevents the
centre of the balloon expanding. If a larger communication is required, the stent can be post-
dilated. If the communication is too large, the centre of the stent can be constricted with a
gooseneck snare [43].
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Figure 7. ‘Dog-bone’ stenting the atrial septum. (a) Brockenbrough needle transseptal puncture; (b) A wire is intro‐
duced into the left pulmonary vein, and a stent mounted on a balloon is advanced through a long sheath. The stent
balloon assembly is half-unsheathed so that the distal half of the stent can be inflated and pulled back against the atrial
septum; (c) As the sheath is pulled back to the right atrium to expose the whole stent, contrast injected through the
side arm of the sheath defines the plane of the atrial septum and shows the stent is well centred; (d) The stent has been
deployed across the atrial septum (arrow). There is a central waist which stabilises the stent on the septum. The waist
was produced by tying a loop of prolene around the middle of the balloon before the stent was mounted. Myocardial
biopsy is also shown.
Figure 8. Implanting a straight stent across the atrial septum. (a) Brockenbrough needle transseptal puncture. The ar‐
row highlights the small radio-opaque marker at the tip of the ECMO cannula. Most of the distal cannula is radiolu‐
cent; (b) The tip of the transseptal sheath is in the left atrium. Contrast injected into the left atrium defines the plane of
the atrial septum (arrow heads); (c) A balloon mounted stent was deployed, but was not well centred on the septum. A
second stent was therefore implanted overlapping the first stent to prevent embolisation; (d) The balloon and wire
have been removed, leaving the 2 overlapping stents in a stable position.
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3.3.7. Does the atrial communication need to be closed after the patient recovers?
Patients who survive ECMO after left atrial decompression should have routine follow-up
echocardiography to check whether the atrial septal defect has closed. One study found that
80% of such patients had a residual defect and 44% required either transcatheter or surgical
closure [33]. However, this may be an overestimate, as less than 20% of patients in another
series had residual defects, and only one of those patients needed device closure [32].
3.4. Patients with haemodynamically unstable refractory arrhythmias
3.4.1. Why is ECMO required in arrhythmia patients?
Patients with haemodynamically unstable arrhythmias fall into two main categories:
(1) Adults with ventricular arrhythmias; (2) infants with tachycardia mediated cardiomyop‐
athy secondary to incessant supraventricular tachycardia [44]. Such patients may require
ECMO because (a) there is an abrupt haemodynamic deterioration; (b) there is no therapeutic
window for drug treatment, because antiarrhythmic drugs have caused an unacceptable
deterioration in the patient’s haemodynamics; (c) catheter ablation is indicated but cannot
proceed without extracorporeal support, either because the patient cannot maintain cardiac
output in tachycardia or because the patient’s haemodynamics are so precarious that there is
a significant risk of cardiac arrest during the procedure.
3.4.2. ECMO support of VT ablation in adult patients
It is debatable whether adult patients with haemodynamically unstable VT benefit from
ablation with ECMO support. ECMO certainly provides a stable platform to carry out
activation mapping of VT where the arrhythmia is not haemodynamically tolerated [45].
However, VT ablation can now be carried out by substrate mapping, which does not require
the patient to remain in the unstable tachycardia. The authors of a leading article in 2009 that
advocated VT ablation with ECMO support have now retreated from that position [45]. They
point out that greater experience with substrate mapping and the widespread availability of
three-dimensional mapping systems have allowed the vast majority of haemodynamically
unstable VTs to be successfully treated during sinus rhythm with very reasonable long-term
success rates and very low morbidity. Their use of ECMO support for VT ablation therefore
fell from 9% (2003–2007) to 0.5% (2007–2012) [46]. There will inevitably be cases where patients
with VT require extracorporeal CPR or urgent ECMO for critically compromised haemody‐
namics. In such patients, who are small in number, it is sensible to proceed to ablate the VT
whilst on mechanical support [47]. However, the era of elective ECMO support to allow
activation mapping seems to have passed.
3.4.3. When is radiofrequency ablation on ECMO necessary in infancy?
In infants with tachycardia-related cardiomyopathy, ECMO is commenced when drug
refractory incessant tachycardia causes progressive deterioration in haemodynamics or when
antiarrhythmic drugs cause cardiovascular collapse requiring extracorporeal CPR [23, 48].
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Once the patient is receiving extracorporeal support, approximately 2/3 should be treatable
with antiarrhythmic drug therapy alone. However, catheter ablation may be required in about
1/3 patients [44]. Ablation may be necessary because the tachyarrhythmia is truly drug
resistant. However, ablation is also reasonable when the tachycardia is very difficult to control
on ECMO, requiring high-dose or multiple antiarrhythmic medications, as invasive treatment
can shorten the duration of ECMO support and minimise the risk of tachycardia recurrence
[23, 48]. It is important to avoid tachycardia recurrence following decannulation as it is may
be very difficult to recannulate the neck vessels if the child becomes unstable again.
3.4.4. Elective use of ECMO to support paediatric ablation procedures
ECMO can be used to electively support paediatric ablation procedures when patients cannot
maintain an adequate cardiac output in tachycardia, either because of congenital heart disease
or poor ventricular function, and mapping in tachycardia is an essential part of the procedure
[49]. In such procedures, the length of time the patient will need to spend in tachycardia, the
degree of haemodynamic impairment this will cause, the size of the patient, the technical
difficulty of the ablation and the possibility of extracorporeal CPR being required all factor
into the decision to use ECMO pre-emptively.
3.4.5. Technical aspects
Very few publications focus on catheter ablation of arrhythmias in children on ECMO.
Although some of the larger series dealing with paediatric cardiac catheterisation on ECMO
include a few patients who had ablation, only basic information is provided [2, 5]. The sum
total of published information consists of 13 patients described in a multicentre review [44]
and 16 patients described in various case reports and case series [2, 5, 22, 23, 48–54], with
possible overlap between these sources.
Atrial septostomy may be needed at the same time as ablation when left heart distension has
developed on ECMO, as ventricular function and cardiac output may take several days to
improve after the tachycardia is successfully ablated [22, 23, 44, 51]. Left atrial decompression
may speed up resolution of pulmonary oedema, improve function and shorten the time to
decannulation.
Most infant ablation procedures on ECMO are carried out with 2 vascular access points. A
single diagnostic catheter and a 5 Fr 4-mm tip ablation catheter are usually used [44]. An
oesophageal bipolar electrode can be added for atrial sensing and stimulation [48]. The largest
study described an average of two ablation substrates per patient. Right-sided accessory
pathways and left-sided ventricular tachycardia were the most common ablation targets.
About 69% were successfully treated with radiofrequency ablation alone. In 29% cases, there
were problems with convective cooling of the catheter tip, resulting in inadequate lesion
formation. Energy delivery and thermodynamics were not improved by reducing ECMO flow
to increase blood flow through the heart. After converting to cryoablation, the tachycardias
were successfully ablated. Although this series described a procedural success rate of 100%,
the complication rate was 15%, with one patient suffering transient heart block and one mitral
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valve damage that ultimately required valve replacement [44]. The desire to produce effective
lesions to avoid tachycardia recurrence must be tempered by caution. Lesion depth should be
kept at a minimum to reduce the risk of perforation and damage to adjacent cardiac structures,
such as valves or coronary arteries, which are particularly close to the endocardium of the
atrioventricular junction in infants. There are no robust data to suggest how much energy
should be delivered to achieve this balance. Although successful ablation has been described
with energy as low as 5 W [23], we recommend initially setting up the ablator to deliver 20 s
lesions at a power of 10 W with a temperature limit of 50° when treating infants. Where
convective cooling does not allow delivery of an effective lesion, successful ablation can also
be achieved with a cooled tip ablation catheter [23].
3.5. Percutaneous coronary intervention on ECMO in critically ill patients
3.5.1. Types of mechanical support available for percutaneous coronary intervention
There are occasions when percutaneous coronary intervention (PCI) cannot be carried out
without additional haemodynamic support. The characteristic scenarios are cardiac arrest,
cardiogenic shock and global critical coronary perfusion status. In these circumstances, various
types of mechanical circulatory support are available, including VA ECMO, intra-aortic
balloon pump, Impella (Abiomed, Danvers, MA) and Tandem Heart (Cardiac Assist, Inc.,
Pittsburgh, PA). Impella uses an axial flow pump to propel blood from the left ventricle to the
aorta. Tandem Heart pumps blood extracorporeally from the left atrium to the femoral artery
via a transseptally placed left atrial cannula. Current evidence on the utility of these devices
is summarised in the 2015 SCAI/ACC/HFSA/STS consensus statement on mechanical circula‐
tory support [55]. Choice between these various modalities is dictated by the patients’
haemodynamic status, availability of equipment and local expertise. In our centre, where there
is a large ECMO programme and considerable experience with emergent use of ECMO,
Figure 9. Circumflex occlusion (arrow) following mitral valve replacement. Stent implantation successfully opened the
occluded segment.
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patients are more likely to receive ECMO support when their haemodynamic status is critically
compromised. ECMO should be chosen in preference to other ventricular assist devices when
there is impaired oxygenation or right ventricular failure. Post-operative patients on ECMO
may occasionally require PCI when there is an unexpected coronary lesion (Figure 9).
3.5.2. PCI on ECMO in patients who have a cardiac arrest
Patients who have cardiac arrest before or during PCI present the greatest challenge to the
interventional team. To carry out PCI while there is no spontaneous cardiac output is extremely
difficult. Manual CPR in this setting, even if performed to perfection, requires pauses for X-
ray imaging and soon becomes ineffective in most cases. When extracorporeal CPR is instituted
soon after cardiac arrest, it provides a haemodynamically stable platform for PCI that allows
the operator to focus on the technique itself, rather than dealing with volatile haemodynamics
and a jerky, mobile X-ray view of the target vessel. There are reports of excellent outcomes
from PCI in patients on ECMO following cardiac arrest [56–61]. However, Kagawa et al.
described only 29% 30-day survival in 61 patients with acute coronary syndrome who received
emergency ECMO coupled with PCI to treat cardiac arrest unresponsive to manual CPR [62].
Arlt et al. described 40% survival to hospital discharge in a cohort of patients who received
PCI coupled with extracorporeal CPR using a miniaturised ECMO system [63]. Better results
were described in the CHEER trial, which included 26 patients with resistant cardiac arrest
who were treated with emergency ECMO, combined with 30 ml/kg of intravenous ice-cold
saline to induce therapeutic hypothermia. Eleven of these patients proceeded to have PCI on
ECMO. Six patients survived with full neurological recovery [64]. A well-organised extracor‐
poreal CPR service is important to achieve the best outcomes in this context. Patients should
be established on ECMO quickly by an expert team, following high-quality CPR without severe
metabolic disturbance or tissue hypoxia, to maximise their chance of survival with intact
neurology.
3.5.3. PCI on ECMO in patients with profound cardiogenic shock
When patients who require PCI present with severe cardiogenic shock (usually defined as
systolic blood pressure less than 75 mmHg on high-dose inotropic support), extracorporeal
support can be used to offload the left ventricle and boost cardiac output during revasculari‐
sation. Recent studies have suggested that survival is improved when ECMO is used as an
adjunct to PCI in this patient group. Esper et al. [65] showed an impressive 67% survival to
discharge in patients with severe shock who received ECMO in the cardiac catheter laboratory.
Good outcome has also been demonstrated following left main stem PCI in patients with
cardiogenic shock supported by ECMO [66]. Data from true randomised comparison of
outcomes with and without ECMO are absent. However, comparison between present and
historic cohorts provides some insight. Sheu et al. [67] demonstrated a statistically significant
reduction in 30-day mortality in PCI patients with profound shock, from 72% to 39%, following
introduction of ECMO support in 2002. Tsao et al. [68] demonstrated a significant difference
in 30-day (32% vs 67%) and 1-year (24% vs 64%) survival in PCI patients with severe shock
when they compared cohorts treated without ECMO (2004–2006) and with ECMO (2007–2009),
Extracorporeal Membrane Oxygenation: Advances in Therapy168
respectively. Unai et al. [69] found similar results after introducing ECMO support for PCI
patients with profound shock in 2010. Existing evidence therefore supports early ECMO
intervention in this patient group, particularly to avoid the peak in mortality that normally
occurs in the first few days after revascularisation [67]. A recent meta-analysis suggests that
this positive effect on in-hospital mortality is found only in patients treated with ECMO and
that treatment with percutaneous left ventricular assist devices, such as the Impella or Tandem
Heart, does not confer a survival benefit [70].
3.5.4. Elective use of ECMO to support high-risk PCI
Percutaneous coronary intervention is regarded as high risk when there is moderate-to-severe
left ventricular dysfunction, a large amount of myocardium is subtended by the stenosed
vessels and, in addition, the procedure involves technical difficulties, such as the presence of
bifurcation lesions, triple vessel disease, left main stenosis or chronic total occlusion. In such
cases, where there is a significant risk that the intervention will precipitate haemodynamic
decompensation, it is intuitive to suppose that elective extracorporeal support will reduce
mortality. Yet, better outcomes have not been convincingly demonstrated in high-risk PCI
procedures supported by intra-aortic balloon pump or Impella [71–73]. In contrast to this, a
recent study using elective Tandem Heart support yielded promising results, with 30-day and
6-month survival rates of 90% and 87%, respectively [73]. From this study, it is tempting to
extrapolate that elective ECMO may improve outcome in this patient group, where the safety
margin is very small. Case reports have certainly described success in high-risk PCI using
ECMO to produce a stable haemodynamic platform [74, 75]. One single-centre prospective
study reported 100% PCI success with no in-hospital major adverse cardiac events in 12
consecutive patients who underwent high-risk PCI with ECMO support. At 6-month follow-
up, neither death nor myocardial infarction were noted [76]. Notwithstanding this, there are
at present no large volume conclusive multicentre trials of these techniques. It is possible that
other means of haemodynamic support may be just as effective as ECMO in these situations.
Technological advances in usability and further attempts at generating good scientific
evidence for the role of ECMO in PCI will go hand in hand and hopefully provide strong
evidence for guideline development in the longer term.
3.6. ECMO support for high-risk elective congenital and structural catheter intervention
procedures
3.6.1. When has elective ECMO support been used for high-risk procedures?
Elective use of ECMO to support high-risk intervention is a new area of practice. There is little
published information. The larger series that deal with paediatric catheterisation on ECMO
do not include data on ECMO use in this context [2–5, 11]. One series dealing with extracor‐
poreal CPR in the paediatric catheter laboratory included two patients with critically low
cardiac output and one with severe hypoxaemia who had elective ECMO support before
catheterisation [77]. The patients survived with no neurological damage. A handful of case
reports have also shown that elective ECMO before catheterisation allows procedures to be
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undertaken safely in patients with extremely fragile haemodynamics. Interventions included
branch pulmonary artery stenting [78, 79], radiofrequency ablation of a Mahaim pathway [49],
radiofrequency ablation of VT [52] and tricuspid valve implantation [80]. In adult patients,
100% procedural success and 0% mortality were described in a small very high-risk TAVI
cohort where ECMO was instituted electively before the procedure. These results were clearly
superior to those cases where high-risk TAVI patients were rescued by emergency ECMO
during the procedure [28]. Such ‘ECMO hybrid procedures’ allow us to deal with increasingly
complex interventional problems in sicker patients without increasing mortality.
3.6.2. The team approach to using ECMO in high-risk catheter procedures
In our catheter laboratory, the risks of procedures that could potentially have catastrophic
complications are mitigated by collaboration with the ECMO team. Whenever there is a
significant possibility of lethal complications, the case is discussed with the interventional
team, the ECMO team, cardiac intensivists and cardiac surgeons. A joint plan is made in
advance at a multidisciplinary team meeting. A detailed team briefing then takes place on the
morning of the procedure, with all disciplines represented. Participants are encouraged to raise
any potential issues in advance. It is important to plan as much as possible before the proce‐
dure, anticipating difficulties rather than reacting to them as they occur [81].
3.6.3. Our local 3 level strategy to support high-risk catheter procedures
Depending on the perceived level of risk, we have three different levels of ECMO support:
3.6.3.1. Level 1
The first level of support is used for cases where serious complications are possible but
unlikely. We include duct stenting or right ventricular outflow tract stenting in this category,
as it is possible that the patient’s only source of pulmonary blood supply can be compromised
by the intervention. In such cases, the ECMO team and surgical team are made aware that the
procedure is taking place, but no special precautions are taken. Sharing information cuts down
the response time, should extracorporeal CPR become necessary.
3.6.3.2. Level 2
The second level of support is used for cases where there is a significant possibility of a lethal
complication. In this category, we include patients undergoing stenting and high-pressure
balloon dilation of a calcific right ventricle to pulmonary artery conduit, particularly where
aggressive dilation is planned at a site where rupture would be difficult to control with a
covered stent, for example at the pulmonary artery bifurcation. If there is a massive rupture,
the only possible rescue strategy may be to occlude the entire conduit with a balloon and place
the patient on VA ECMO while preparations are made for cardiac surgery. In such cases, in
addition to the vascular access that is required to perform the intervention, we place an extra
sheath in the contralateral femoral artery and vein. These sheaths can be rewired and used for
percutaneous ECMO cannulation in an emergency. An ECMO circuit is assembled and kept
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in the catheter laboratory. Blood and products are prepared in advance as if the patient were
going for cardiac surgery. The ECMO team, a cardiac surgeon and a theatre team remain in
the catheter laboratory during the procedure, and a cardiac theatre is kept free. When the risk
is particularly high and the response needs to be immediate, the ECMO circuit is primed with
blood before the procedure starts. High-risk neonatal interventions in this category involve
preparing the neck for cannulation rather than the groin. This may consist of prepping and
draping the neck area and inserting a sheath that can be easily rewired into the jugular vein
or may extend to cut down and exposure of the neck vessels for cannulation in very high-risk
cases.
3.6.3.3. Level 3
The third level of support is reserved for patients with poor ventricular function and low
cardiac output, where there is a high risk of cardiac arrest or acute haemodynamic
decompensation during the catheter procedure (Figure 10). Also in this category are patients
who have critically low oxygen saturation because of narrowed shunts or branch pulmonary
arteries, where pulmonary blood flow will be further compromised during the intervention.
In these patients, ECMO is electively instituted in advance of the case while the patient is on
the intensive care unit. We have used this approach to carry out conduit stenting in an adult
patient with gross right heart failure secondary to severe chronic right ventricle to pulmonary
artery conduit stenosis. The patient, who had an excellent result, was decannulated on the
Figure 10. Elective ECMO support of right ventricle to pulmonary artery conduit stenting. (a) Angiography shows a
tight stenosis in the right ventricle to pulmonary artery conduit; (b) A covered stent is implanted in the conduit. Fur‐
ther stents were subsequently implanted and dilated with a high-pressure balloon; (c) A Melody (Medtronic, Minneap‐
olis, MN) percutaneous pulmonary valve is implanted in the prestented conduit at a second procedure 5 months later;
(d) A well-expanded conduit with a competent pulmonary valve is ultimately achieved.
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same day as the procedure and ultimately had successful percutaneous pulmonary valve
implantation.
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